Profilo
David M.
Brand is the founder of Tarsa Therapeutics, Inc., founded in 2009, where the title held is Director.
Former jobs include President & Chief Executive Officer at CardioKine, Inc. from 2004 to 2007, Director at InteKrin Therapeutics, Inc., Director at NeurAxon, Inc., Principal at Biogen, Inc., Vice President at GlaxoSmithKline, Inc., and Principal at Cie de Recherches d'Etude et de Gestion Immobilière SA. Education includes undergraduate studies at Concordia University.
Posizioni attive di David M. Brand
| Società | Posizione | Inizio |
|---|---|---|
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral treatment for post-menopausal osteoporosis | Fondatore | 01/01/2009 |
Precedenti posizioni note di David M. Brand
| Società | Posizione | Fine |
|---|---|---|
CardioKine, Inc.
CardioKine, Inc. Pharmaceuticals: MajorHealth Technology Develop drugs and pharmaceuticals for the treatment and prevention of heart failure | Presidente | 01/09/2007 |
Cie de Recherches d'Etude et de Gestion Immobilière SA
Cie de Recherches d'Etude et de Gestion Immobilière SA Real Estate Investment TrustsFinance Specializes in real-estate investments | Corporate Officer/Principal | - |
| BIOGEN INC. | Corporate Officer/Principal | - |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for metabolic and immune disorders | Direttore/Membro del Consiglio | - |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | Direttore/Membro del Consiglio | - |
Formazione di David M. Brand
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
CardioKine, Inc.
CardioKine, Inc. Pharmaceuticals: MajorHealth Technology Develop drugs and pharmaceuticals for the treatment and prevention of heart failure | Health Technology |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for metabolic and immune disorders | Health Technology |
Concordia University
Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Cie de Recherches d'Etude et de Gestion Immobilière SA
Cie de Recherches d'Etude et de Gestion Immobilière SA Real Estate Investment TrustsFinance Specializes in real-estate investments | Finance |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | Commercial Services |
Tarsa Therapeutics, Inc.
Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral treatment for post-menopausal osteoporosis | Health Technology |
















